(Reuters) -Pfizer and partner BioNTech said on Monday their updated COVID-19 vaccine showed an increased immune response in adults aged 65 and older as well as those aged 18 through 64 with at least one underlying risk condition.

(Reporting by Sriparna Roy in Bengaluru; Editing by Shreya Biswas)

See Full Page